Literature DB >> 21039113

Illicit drug use and treatment in South Africa: a review.

Karl Peltzer1, Shandir Ramlagan, Bruce D Johnson, Nancy Phaswana-Mafuya.   

Abstract

This review synthesizes available epidemiological data on current drug use and substance user treatment admissions in South Africa since 1994, and how changes in the political, economic, and social structures within South Africa, both before and after Apartheid, has made the country more vulnerable to drug use. Based on national surveys, current use of cannabis ranged among adolescents from 2% to 9% and among adults it was 2%, cocaine/crack (0.3%), mandrax/sedatives (0.3%), club drugs/amphetamine-type stimulants (0.2%), opiates (0.1%), and hallucinogens (0.1%). The use of primary illicit substance at admission to South African drug user treatment centers was cannabis 16.9%, methamphetamine (tik) 12.8%, crack/cocaine 9.6%, cannabis and mandrax 3.4%, heroin/opiates 9.2%, and prescription and OTC drugs 2.6%. An increase in substance user treatment admissions has increased. While the prevalence of illicit drug use in South Africa is relatively low compared to the United States and Australia, prevention and intervention policies need to be designed to reduce these levels by targeting the more risky subpopulations identified from this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039113      PMCID: PMC3010753          DOI: 10.3109/10826084.2010.481594

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  6 in total

1.  Substance use by adolescents in Cape Town: prevalence and correlates.

Authors:  Alan J Flisher; Charles D H Parry; Janet Evans; Martie Muller; Carl Lombard
Journal:  J Adolesc Health       Date:  2003-01       Impact factor: 5.012

2.  Heroin treatment demand in South Africa: trends from two large metropolitan sites (January 1997-December 2003).

Authors:  Charles D H Parry; Andreas Plüddemann; Bronwyn J Myers
Journal:  Drug Alcohol Rev       Date:  2005-09

3.  Cultural orientation and use of cannabis and inhalants among secondary school children in Zimbabwe.

Authors:  A H Eide; S W Acuda
Journal:  Soc Sci Med       Date:  1997-10       Impact factor: 4.634

4.  Risk-taking behaviour of Cape Peninsula high-school students. Part V. Drug use.

Authors:  A J Flisher; C F Ziervogel; D O Chalton; P H Leger; B A Robertson
Journal:  S Afr Med J       Date:  1993-07

5.  Trends in adolescent alcohol and other drug use: findings from three sentinel sites in South Africa (1997-2001).

Authors:  Charles D H Parry; Bronwyn Myers; Neo K Morojele; Alan J Flisher; Arvin Bhana; Hilton Donson; Andreas Plüddemann
Journal:  J Adolesc       Date:  2004-08

6.  Cocaine treatment admissions at three sentinel sites in South Africa (1997-2006): findings and implications for policy, practice and research.

Authors:  Charles D H Parry; Andreas Plüddemann; Bronwyn J Myers
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-12-28
  6 in total
  38 in total

1.  "Nothing Is Free": A Qualitative Study of Sex Trading Among Methamphetamine Users in Cape Town, South Africa.

Authors:  Melissa H Watt; Stephen M Kimani; Donald Skinner; Christina S Meade
Journal:  Arch Sex Behav       Date:  2015-01-08

2.  Addiction and treatment experiences among active methamphetamine users recruited from a township community in Cape Town, South Africa: A mixed-methods study.

Authors:  Christina S Meade; Sheri L Towe; Melissa H Watt; Ryan R Lion; Bronwyn Myers; Donald Skinner; Stephen Kimani; Desiree Pieterse
Journal:  Drug Alcohol Depend       Date:  2015-04-30       Impact factor: 4.492

3.  Intimate partner violence among men and women who use methamphetamine: A mixed-methods study in South Africa.

Authors:  Melissa H Watt; Kathryn E Guidera; Andréa L Hobkirk; Donald Skinner; Christina S Meade
Journal:  Drug Alcohol Rev       Date:  2016-06-01

4.  HIV Risk Behavior Among Methamphetamine Users Entering Substance Abuse Treatment in Cape Town, South Africa.

Authors:  Christina S Meade; Ryan R Lion; Daniella M Cordero; Melissa H Watt; John A Joska; Hetta Gouse; Warren Burnhams
Journal:  AIDS Behav       Date:  2016-10

5.  Prenatal methamphetamine exposure is associated with reduced subcortical volumes in neonates.

Authors:  Fleur L Warton; Ernesta M Meintjes; Christopher M R Warton; Christopher D Molteno; Nadine M Lindinger; R Colin Carter; Lilla Zöllei; Pia Wintermark; Joseph L Jacobson; Andre van der Kouwe; Sandra W Jacobson
Journal:  Neurotoxicol Teratol       Date:  2017-10-22       Impact factor: 3.763

6.  Prenatal methamphetamine exposure is associated with corticostriatal white matter changes in neonates.

Authors:  Fleur L Warton; Paul A Taylor; Christopher M R Warton; Christopher D Molteno; Pia Wintermark; Nadine M Lindinger; Lilla Zöllei; Andre van der Kouwe; Joseph L Jacobson; Sandra W Jacobson; Ernesta M Meintjes
Journal:  Metab Brain Dis       Date:  2017-10-23       Impact factor: 3.584

7.  A qualitative study of methamphetamine initiation in Cape Town, South Africa.

Authors:  Andréa L Hobkirk; Melissa H Watt; Bronwyn Myers; Donald Skinner; Christina S Meade
Journal:  Int J Drug Policy       Date:  2015-10-28

8.  Spending money to make change: Association of methamphetamine abstinence and voucher spending among contingency management pilot participants in South Africa.

Authors:  Tamar Krishnamurti; Kimberly Ling Murtaugh; Lara Van Nunen; Alexander L Davis; Jonathan Ipser; Steven Shoptaw
Journal:  J Subst Abuse Treat       Date:  2020-01-25

9.  Latent class analysis of polysubstance use, sexual risk behaviors, and infectious disease among South African drug users.

Authors:  Rebecca C Trenz; Michael Scherer; Alexandra Duncan; Paul T Harrell; Anne Gloria Moleko; William W Latimer
Journal:  Drug Alcohol Depend       Date:  2013-04-03       Impact factor: 4.492

10.  Trajectories of initiation for the heroin-based drug whoonga - qualitative evidence from South Africa.

Authors:  Griffin A Tyree; Nzwakie Mosery; Elizabeth F Closson; Zonke Mabude; Carol du Toit; David R Bangsberg; Steven A Safren; Kenneth H Mayer; Jennifer A Smit; Matthew J Mimiaga; David J Grelotti
Journal:  Int J Drug Policy       Date:  2020-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.